All regulations
Nonrulemaking
FDA
FDA-2026-E-4539
Patent Term Application for YUVIWEL (navipegritide) Patent No. 11,154,593
Documents
2
Comments
0
Key Dates
Comment Period OpensApr 27, 2026
Documents
Keywords
CDER
Alston and Bird LLP
Ascendis Pharma Growth Disorders AS
Patent Term Application
for YUVIWEL (navipegritide)
Patent No 11154593
OPEN
Data from Regulations.gov